Stockscreener 앱 받기
0.823
2.26%
-0.019
전일 마감가:
$0.842
열려 있는:
$0.83
하루 거래량:
13,956
Relative Volume:
0.08
시가총액:
$29.76M
수익:
-
순이익/손실:
$-8.53M
주가수익비율:
-3.3813
EPS:
-0.2434
순현금흐름:
$-12.75M
1주 성능:
-3.73%
1개월 성능:
-5.55%
6개월 성능:
-26.52%
1년 성능:
-40.79%
1일 변동 폭
$0.8229
$0.87
1주일 범위
$0.7836
$0.87
52주 변동 폭
$0.63
$1.78
Estrella Immunopharma Inc Stock (ESLA) Company Profile
명칭
Estrella Immunopharma Inc
전화
(510) 318-9098
주소
5858 HORTON STREET, SUITE 370, EMERYVILLE
ESLA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ESLA
Estrella Immunopharma Inc
|
0.823 | 30.36M | 0 | -8.53M | -12.75M | -0.2434 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Estrella Immunopharma Inc 주식(ESLA)의 최신 뉴스
How high can Estrella Immunopharma Inc. stock goLow-Risk Reversal Pattern Analysis Tracker - Newser
Should you wait for a breakout in Estrella Immunopharma Inc.Trade Safety Report with Pattern Insights - Newser
Is Estrella Immunopharma Inc. stock reversal real or fakeStock Price Prediction Using AI Tools - Newser
Estrella Immunopharma Faces Nasdaq Non-Compliance Notice - MSN
How Estrella Immunopharma Inc. stock performs during market volatilityMomentum Stocks with Breakout Potential - Newser
Should you hold or exit Estrella Immunopharma Inc. nowTrade Safety Report with Pattern Insights - Newser
How to monitor Estrella Immunopharma Inc. with trend dashboardsAI-Powered Stock Trend Movement Analysis - Newser
Using data tools to time your Estrella Immunopharma Inc. exitFree High Yield Stock Screening Results - Newser
Analyzing Estrella Immunopharma Inc. with risk reward ratio chartsCapital Secure Pattern Signal Analysis Sheet - Newser
Trend analysis for Estrella Immunopharma Inc. this weekFree Market Entry and Exit Point Tips - Newser
Analyzing recovery setups for Estrella Immunopharma Inc. investorsFree Risk Controlled Picks With Real Returns - Newser
Can Estrella Immunopharma Inc. rally from current levelsSmart Entry Watchlist with Daily Analysis - Newser
Advanced analytics toolkit walkthrough for Estrella Immunopharma Inc.Free Oversold Bounce Stock Play Ideas - Newser
What earnings revisions data tells us about Estrella Immunopharma Inc.Market Downturn Defense Strategy Analysis - Newser
Why Estrella Immunopharma Inc. stock attracts strong analyst attentionFree Capital Protection Trading Strategies - Newser
Is Estrella Immunopharma Inc. stock overvalued or undervaluedAccelerated wealth expansion - Jammu Links News
What is Estrella Immunopharma Inc. company’s growth strategyRobust investment performance - Jammu Links News
How strong is Estrella Immunopharma Inc. company’s balance sheetSuperior investment outcomes - Jammu Links News
What are Estrella Immunopharma Inc. company’s key revenue driversUnlock powerful trading signals for profits - Jammu Links News
How does Estrella Immunopharma Inc. compare to its industry peersMaximize returns with smart investment plans - Jammu Links News
Visualizing Estrella Immunopharma Inc. stock with heatmapsWatchlist Generator for Smart Money Signals - Newser
Why is Estrella Immunopharma Inc. stock attracting strong analyst attentionRapid growth opportunities - Jammu Links News
Is it the right time to buy Estrella Immunopharma Inc. stockUnlock steady growth with low-risk stocks - Jammu Links News
When is Estrella Immunopharma Inc. stock expected to show significant growthGet real-time alerts on top stocks - Jammu Links News
What are analysts’ price targets for Estrella Immunopharma Inc. in the next 12 monthsExplosive returns - Jammu Links News
What Fibonacci levels say about Estrella Immunopharma Inc. reboundPattern Recognition Tool for ROI Investors - Newser
Understanding Estrella Immunopharma Inc.’s price movementSwing Gain Strategy with Entry Forecast - Newser
Using data filters to optimize entry into Estrella Immunopharma Inc.AI Enhanced Strategy for Portfolio Growth - Newser
Estrella Immunopharma Inc (ESLA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):